Showing results (791-800 of 942) with videos related to

Sort By:
Pageof 95
JAMA Cardiology|September 1, 2025
Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical TrialSiddharth M Patel, Robert P Giugliano, David A Morrow, et al.
JAMA Cardiology|April 16, 2020
Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System ChangesAnubodh S Varshney, David D Berg, Jason N Katz, et al.
European Heart Journal|September 22, 2018
Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trialsDavid D Berg, Stephen D Wiviott, Eugene Braunwald, et al.
Circulation|November 17, 2020
Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19: Findings From the American Heart Association's COVID-19 Cardiovascular Disease RegistryFatima Rodriguez, Nicole Solomon, James A de Lemos, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 19, 2026
Myelin damage in radiologically isolated syndrome is associated with decreased processing speedOlivia Kalau, Poljanka Johnson, Jiwon Oh, et al.
BMC Neurology|February 11, 2019
Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trialC R A Silveira, J MacKinley, K Coleman, et al.
JACC. Advances|August 21, 2025
In-Hospital Mortality Risk Among Transfers to Cardiac Intensive Care UnitsNicholas Phreaner, Miguel Alvarez Villela, Courtney E Bennett, et al.
Circulation|February 15, 2021
Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trialsEmily S Lau, Eugene Braunwald, David A Morrow, et al.
JAMA Cardiology|April 30, 2020
Effect of Evolocumab on Type and Size of Subsequent Myocardial Infarction: A Prespecified Analysis of the FOURIER Randomized Clinical TrialStephen D Wiviott, Robert P Giugliano, David A Morrow, et al.
American Heart Journal|December 9, 2020
Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) InvestigatorsAnthony P Carnicelli, Hwanhee Hong, Robert P Giugliano, et al.
Pageof 95